Intracellular Phosphate and ATP Depletion Measured by Magnetic Resonance Spectroscopy in Patients Receiving Maintenance Hemodialysis

被引:22
作者
Chazot, Guillaume [1 ]
Lemoine, Sandrine [1 ,2 ,3 ]
Kocevar, Gabriel [4 ]
Kalbacher, Emilie [1 ]
Sappey-Marinier, Dominique [4 ,5 ]
Rouviere, Olivier [6 ,7 ]
Juillard, Laurent [1 ,2 ,3 ]
机构
[1] Hop Edouard Herriot, Serv Nephrol & Explorat Fonct Renale, Hosp Civils Lyon, Lyon, France
[2] Univ Claude Bernard, INSA Lyon, Univ Lyon,U1060, CARMEN,Inst Natl Sante & Rech Med Cardiovasc Meta, Bron, France
[3] Univ Claude Bernard, CREATIS Ctr Rech & Applicat Traitement Image & Si, Unite Mixte Rech 5220, Univ Lyon,Ctr Natl Rech Sci,INSA Inst Natl Sci Ap, Villeurbanne, France
[4] Univ Claude Bernard, Univ Lyon, INSA Inst Natl Sci Appl Lyon, Inst Natl Sante & Rech Med U1206, Villeurbanne, France
[5] Univ Lyon, CERMEP Imagerie Vivant, Ctr Etud & Rech Med Emiss Positons, Bron, France
[6] Hosp Civils Lyon, Serv Radiol, Hop Edouard Herriot, Lyon, France
[7] Univ Claude Bernard, Univ Lyon, Labtau Inst Natl Sante & Rech Med U1032, Villeurbanne, France
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 01期
关键词
chronic hemodialysis; hyperphosphatemia; cell transfer; IMPAIRED ENERGY-METABOLISM; RESPIRATORY-FAILURE; DIALYSIS OUTCOMES; SKELETAL-MUSCLE; MORTALITY RISK; PHOSPHORUS; HYPOPHOSPHATEMIA; CALCIUM; CONSEQUENCES; NMR;
D O I
10.1681/ASN.2020050716
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background The precise origin of phosphate that is removed during hemodialysis remains unclear; only a minority comes from the extracellular space. One possibility is that the remaining phosphate originates from the intracellular compartment, but there have been no available data from direct assessment of intracellular phosphate in patients undergoing hemodialysis. Methods We used phosphorusmagnetic resonance spectroscopy to quantify intracellular inorganic phosphate (Pi), phosphocreatine (PCr), and beta ATP. In our pilot, single-center, prospective study, 11 patients with ESKD underwent phosphorus (P-31) magnetic resonance spectroscopy examination during a 4-hour hemodialysis treatment. Spectra were acquired every 152 seconds during the hemodialysis session. The primary outcome was a change in the PCr-Pi ratio during the session. Results During the first hour of hemodialysis, mean phosphatemia decreased significantly (-41%; P<0.001); thereafter, it decreased more slowly until the end of the session. We found a significant increase in the PCr-Pi ratio (+23%; P=0.001) during dialysis, indicating a reduction in intracellular Pi concentration. The PCr-beta ATP ratio increased significantly (+31%; P=0.001) over a similar time period, indicating a reduction in beta ATP. The change of the PCr-beta ATP ratio was significantly correlated to the change of depurated Pi. Conclusions Phosphorus magnetic resonance spectroscopy examination of patients with ESKD during hemodialysis treatment confirmed that depurated Pi originates from the intracellular compartment. This finding raises the possibility that excessive dialytic depuration of phosphate might adversely affect the intracellular availability of high-energy phosphates and ultimately, cellular metabolism. Further studies are needed to investigate the relationship between objective and subjective effects of hemodialysis and decreases of intracellular Pi and beta ATP content.
引用
收藏
页码:229 / 237
页数:9
相关论文
共 32 条
[1]   Hypophosphatemia: an evidence-based approach to its clinical consequences and management [J].
Amanzadeh, J ;
Reilly, RF .
NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (03) :136-148
[2]   Hypophosphatemia-induced Cardiomyopathy [J].
Ariyoshi, Nobuhiro ;
Nogi, Masayuki ;
Ando, Akika ;
Watanabe, Hideaki ;
Umekawa, Sari .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 352 (03) :317-323
[3]   METABOLIC RECOVERY AFTER EXERCISE AND THE ASSESSMENT OF MITOCHONDRIAL-FUNCTION INVIVO IN HUMAN SKELETAL-MUSCLE BY MEANS OF P-31 NMR [J].
ARNOLD, DL ;
MATTHEWS, PM ;
RADDA, GK .
MAGNETIC RESONANCE IN MEDICINE, 1984, 1 (03) :307-315
[4]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[5]   IMPAIRED ENERGY-METABOLISM IN SKELETAL-MUSCLE DURING PHOSPHATE-DEPLETION [J].
BRAUTBAR, N ;
CARPENTER, C ;
BACZYNSKI, R ;
KOHAN, R ;
MASSRY, SG .
KIDNEY INTERNATIONAL, 1983, 24 (01) :53-57
[6]   ACUTE DIALYSIS HYPERCALCEMIA AND DIALYSIS PHOSPHATE LOSS [J].
CARNEY, SL ;
GILLIES, AHB .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (05) :377-382
[7]   INTRAMYOCELLULAR PHOSPHATE-METABOLISM IN X-LINKED HYPOPHOSPHATEMIC RICKETS [J].
CLARKE, GD ;
KAINER, G ;
CONWAY, WF ;
CHAN, JCM .
JOURNAL OF PEDIATRICS, 1990, 116 (02) :288-292
[8]   Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy [J].
Crilley, JG ;
Boehm, EA ;
Blair, E ;
Rajagopalan, B ;
Blamire, AM ;
Styles, P ;
McKenna, WJ ;
Östman-Smith, I ;
Clarke, K ;
Watkins, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1776-1782
[9]   A two-pool kinetic model predicts phosphate concentrations during and shortly following a conventional (three times weekly) hemodialysis session [J].
Daugirdas, John T. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (01) :76-84
[10]   Removal of Phosphorus by Hemodialysis [J].
Daugirdas, John T. .
SEMINARS IN DIALYSIS, 2015, 28 (06) :620-623